Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Derm Allergy/Immunology

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): A factorial, multicentre, cluster-randomised trial

The Lancet | Mar 25, 2020 Derm Allergy/Immunology

Factors associated with short-term relapse in patients with pemphigus who receive rituximab as first-line therapy: A post hoc analysis of a randomized clinical trial

JAMA | Mar 24, 2020 Derm Allergy/Immunology

Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study

Journal of the American Academy of Dermatology | Mar 23, 2020 Derm Allergy/Immunology

The effectiveness of high‐dose ultraviolet A‐1 phototherapy for acute exacerbation of atopic dermatitis in Asians

Photodermatology, Photoimmunology and Photomedicine | Mar 23, 2020 Derm Allergy/Immunology

Comparison of racial distribution of photodermatoses in USA academic dermatology clinics: A multicenter retrospective analysis of 1,080 patients over a 10‐year period

Photodermatology, Photoimmunology and Photomedicine | Mar 19, 2020 Derm Allergy/Immunology

Association of Clinical Markers With Disease Progression in Patients With Vitiligo From China

JAMA | Mar 16, 2020 Derm Allergy/Immunology

Efficacy and safety of lebrikizumab, a high-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: A phase 2b randomized clinical trial

JAMA | Mar 02, 2020 Derm Allergy/Immunology

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): A factorial, multicentre, cluster-randomised trial

The Lancet | Mar 01, 2020 Derm Allergy/Immunology

Trial of nemolizumab in moderate-to-severe prurigo nodularis

New England Journal of Medicine | Feb 27, 2020 Derm Allergy/Immunology

Daily emollient during infancy for prevention of eczema: The BEEP randomised controlled trial

The Lancet | Feb 27, 2020 Derm Allergy/Immunology

« Prev 1 … 25 26 27 28 29 … 57 Next »

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): A factorial, multicentre, cluster-randomised trial

Factors associated with short-term relapse in patients with pemphigus who receive rituximab as first-line therapy: A post hoc analysis of a randomized clinical trial

Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study

The effectiveness of high‐dose ultraviolet A‐1 phototherapy for acute exacerbation of atopic dermatitis in Asians

Comparison of racial distribution of photodermatoses in USA academic dermatology clinics: A multicenter retrospective analysis of 1,080 patients over a 10‐year period

Association of Clinical Markers With Disease Progression in Patients With Vitiligo From China

Efficacy and safety of lebrikizumab, a high-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: A phase 2b randomized clinical trial

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): A factorial, multicentre, cluster-randomised trial

Trial of nemolizumab in moderate-to-severe prurigo nodularis

Daily emollient during infancy for prevention of eczema: The BEEP randomised controlled trial

Article on Hypertension in CKD Patients: Management Updates

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes and Urinary ACR with Dr Saraogi

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

New research aims to transform treatments of aggressive blood cancer

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): A factorial, multicentre, cluster-randomised trial

Factors associated with short-term relapse in patients with pemphigus who receive rituximab as first-line therapy: A post hoc analysis of a randomized clinical trial

Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study

The effectiveness of high‐dose ultraviolet A‐1 phototherapy for acute exacerbation of atopic dermatitis in Asians

Comparison of racial distribution of photodermatoses in USA academic dermatology clinics: A multicenter retrospective analysis of 1,080 patients over a 10‐year period

Association of Clinical Markers With Disease Progression in Patients With Vitiligo From China

Efficacy and safety of lebrikizumab, a high-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: A phase 2b randomized clinical trial

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): A factorial, multicentre, cluster-randomised trial

Trial of nemolizumab in moderate-to-severe prurigo nodularis

Daily emollient during infancy for prevention of eczema: The BEEP randomised controlled trial

Article on Hypertension in CKD Patients: Management Updates

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes and Urinary ACR with Dr Saraogi

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic